Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-17

Clinical Trial Update: Femoral Nerve Block Compared to Exparel in Total Knee Replacement [Phase 3]

View source ↗

Summary

A Phase 3 trial update comparing femoral nerve block with Exparel for pain management in total knee replacement due to osteoarthritis; status is currently UNKNO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)

Snippet

Sponsor: The New England Baptist Hospital | Conditions: Osteoarthritis, Pain | Phase 3 | Status: UNKNOWN